XML 21 R46.htm IDEA: XBRL DOCUMENT v3.2.0.727
Acquisitions (Narrative) (Details)
$ in Thousands
3 Months Ended
Sep. 03, 2014
USD ($)
brand
Jun. 30, 2015
USD ($)
Mar. 31, 2015
USD ($)
Apr. 30, 2014
USD ($)
Business Acquisition [Line Items]        
Purchased amortizable intangible assets, weighted average remaining period   14 years 5 months    
Goodwill   $ 290,867 $ 290,651  
Insight Pharmaceuticals        
Business Acquisition [Line Items]        
Purchase price of acquisition $ 753,200      
Number of pharmaceutical brands acquired as a result of acquisition | brand 27      
Number of brands sold | brand 1      
Non-amortizable intangible assets $ 599,600      
Amortizable intangible assets 124,800      
Purchased amortizable intangible assets, weighted average useful life   16 years 2 months 12 days    
Purchased amortizable intangible assets, weighted average remaining period   15 years 04 months 1 day    
Goodwill 103,560      
Value of assets sold on acquisition date, excluded from purchase price 18,500      
Non-amortizable intangible assets 724,374      
Insight Pharmaceuticals | Intangible assets        
Business Acquisition [Line Items]        
Value of assets sold on acquisition date, excluded from purchase price 17,700      
Insight Pharmaceuticals | Inventory        
Business Acquisition [Line Items]        
Value of assets sold on acquisition date, excluded from purchase price 600      
Insight Pharmaceuticals | Property, plant and equipment        
Business Acquisition [Line Items]        
Value of assets sold on acquisition date, excluded from purchase price $ 200      
Hydralyte        
Business Acquisition [Line Items]        
Goodwill       $ 1,224
Non-amortizable intangible assets       $ 73,580